Fidel Lopez-Verdugo

Fidel Lopez-Verdugo

Auto-generated profile, based on publicly available information

Fidel Lopez-Verdugo

Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Medicine
Verified
Journal Article
Open access
FLFidel Lopez-Verdugo
Fidel Lopez-Verdugo
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
FRFernanda Romero-Hernandez
Fernanda Romero-Hernandez
ECEnrique Coss-Adame
Enrique Coss-Adame
MVMiguel A. Valdovinos
Miguel A. Valdovinos
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos
Complete blood count (CBC)-derived parameters such as neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), eosinophil-to-lymphocyte (ELR) ratio, and platelet-to-lymphocyte ratio (PLR) are sensitive markers of occult inflammation and disease activity for systemic lupus erythematosus, rheumatoid arthritis, psoriasis, esophageal cancer, etc. We assessed NLR, PLR, MLR, and ELR as indicators of inflammation in achalasia patients. This cross-sectional study included 103 achalasia patients and 500 healthy blood donor volunteers (HD). Demographic, clinical and laboratory information was collected. NLR, MLR, ELR and PLR were calculated. Peripheral Th22, Th17, Th2 and Th1 subsets were determined by flow cytometry. Correlation between hematologic indices and clinical questionnaires scores, HRM parameters and CD4+ T-cells were assessed. Hematologic parameters associated with the different achalasia subtypes were evaluated by logistic regression analysis. Hemoglobin, leukocytes, lymphocytes, monocytes, and platelets counts were significantly lower in achalasia patients vs controls. NLR (P = .006) and ELR (P < .05) were higher in achalasia patients vs controls. NLR was significantly associated with achalasia in multivariate analysis (P < .001). Compared to HD, the achalasia group was 1.804 times more likely to have higher NLR (95% CI 1.287–2.59; P < .001). GERD-HRQL score had statistically significant correlations with PLR (Pearson's rho:0.318, P = .003), and ELR (Pearson's rho:0.216; P = .044). No correlation between CD4+ T-cells and hematologic indices were determined. NLR with a cut-off value of ≥2.20 and area under the curve of 0.581 yielded a specificity of 80% and sensitivity of 40%, for the diagnosis of achalasia. NLR is increased in achalasia patients vs HD. Sensitivity and specificity achieved by NLR may contribute to a clinical and manometric evaluation. We suggest these indices as potential indicators of silent inflammation and disease activity.

5 May 2020 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
PDF file
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
ECEnrique Coss‐Adame
Enrique Coss‐Adame
FRFernanda Romero‐Hernández
Fernanda Romero‐Hernández
JZJoaquín Zúñiga
Joaquín Zúñiga
NUNorma Uribe‐Uribe
Norma Uribe‐Uribe
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos
Objective: To determine the differences between clinical, manometric, and neuroimmunological profile of esophagogastric junction outflow obstruction (EGJOO) and achalasia patients.Methods: Seven EGJOO and 27 achalasia patients were enrolled in a blind cross‐sectional study. Peripheral blood (PB) of 10 healthy donors and 10 lower esophageal sphincter (LES) muscle biopsies from organ transplant donors were included as controls. The presence of ganglion cells, cells of Cajal, Th22/Th7/Th2/Th1/Tregs/Bregs/pDCregs in tissue, and PB was assessed by immunohistochemistry and flow cytometry. Serum concentration of IL‐22/IL‐17A/IL‐17F/IL‐4/IFN‐γ/IL‐1β/IL‐6/IL‐23/IL‐33/TNF‐α/IL‐10 was determined using bioplex plates. ANAs and antineuronal antibodies were evaluated by immunofluorescence and Western blot.Key Results: EGJOO and achalasia patients had lower ganglion cells and cells of Cajal percentage vs. controls, while fibrosis was present only in achalasia patients. EGJOO and controls had lower cell percentage of Th22/Th17/Th2 vs. achalasia. EGJOO tissue had lower Th1/Treg cell number vs. achalasia, but higher levels vs. control group. Bregs and pDCregs percentage was higher in EGJOO vs. control group. Percentage of PB subpopulations in EGJOO was not significantly different from control group. Serum cytokine levels were higher for IL‐1β/IL‐6/TNF‐α, while IL‐17A levels were lower in EGJOO vs. achalasia and control group. EGJOO group was negative for ANAs, while in achalasia group, 54% were positive. GAD65 and PNMa/Ta2 antibodies were present in achalasia, whereas Yo and recoverin were positive in EGJOO group.Conclusions and Inferences: Although EGJOO shares some clinical characteristics with achalasia, the neuroimmunological profile is completely different, suggesting that EGJOO might be a different entity.

15 April 2019 in Clinical and Experimental Immunology
Verified
Journal Article
Closed access
PDF file
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
NUN O Uribe-Uribe
N O Uribe-Uribe
JGJose Manuel Arreola Guerra
Jose Manuel Arreola Guerra
RRR Reyes-Acevedo
R Reyes-Acevedo
MVM Vilatobá
M Vilatobá
JAJ Alberú
J Alberú

21 September 2022 in Transplant Infectious Disease
Verified
Journal Article
Closed access
DBDavid B. Banach
David B. Banach
FLFidel Lopez‐Verdugo
Fidel Lopez‐Verdugo
JSJorge Sanchez‐Garcia
Jorge Sanchez‐Garcia
ATAlexandria Tran
Alexandria Tran
AGAdriana Gomez‐Llerena
Adriana Gomez‐Llerena
MRManuel I. Rodriguez‐Davalos
Manuel I. Rodriguez‐Davalos

17 June 2020 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
AOAndric Ortiz
Andric Ortiz
SNSofia Narváez‐Chávez
Sofia Narváez‐Chávez
JFJanette Furuzawa-Carballeda
Janette Furuzawa-Carballeda
ECEnrique Coss‐Adame
Enrique Coss‐Adame
MVMiguel A Valdovinos‐Díaz
Miguel A Valdovinos‐Díaz
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos

28 January 2020 in Neurogastroenterology & Motility
Verified
Journal Article
Open access
PDF file
DHDiego F. Hernández‐Ramírez
Diego F. Hernández‐Ramírez
EOElizabeth Olivares‐Martínez
Elizabeth Olivares‐Martínez
CNCarlos A. Nuñez‐Álvarez
Carlos A. Nuñez‐Álvarez
ECEnrique Coss‐Adame
Enrique Coss‐Adame
MVMiguel A. Valdovinos
Miguel A. Valdovinos
GTGonzalo Torres-Villalobos
Gonzalo Torres-Villalobos
Background: Idiopathic achalasia is an uncommon esophageal motor disorder. The disease involves interaction between inflammatory and autoimmune responses. However, the antigens related to the disease are still unknown.Aim: To identify the possible antigen targets in muscle biopsies from lower esophageal sphincter (LES) of achalasia patients.Methods: Esophageal biopsies of patients with type I and type II achalasia and esophagogastric junction outflow obstruction (EGJOO) were analyzed. Lower esophageal sphincter muscle biopsy from a Healthy organ Donor (HD) was included as control for two‐dimensional gel electrophoresis. Immunoblotting of muscle from LES lysate with sera of type I, type II achalasia, or type III achalasia, sera of EGJOO and sera of healthy subjects (HS) was performed. The target proteins of the serum were identified by mass spectrometry Matrix‐assited laser desorption/ionization time‐of‐flight (MALDI‐TOF).Key Results: The proteomic map of muscle from LES tissue lysates of type I, and type II achalasia, EGJOO, and HD were analyzed and divided into three important regions. We found a difference in the concentration of certain spots. Further, we observed the serum reactivity of type I achalasia and type II achalasia against 45 and 25 kDa bands of type I achalasia tissue. Serum of type III achalasia and EGJOO mainly recognized 25 kDa band. Bands correspond to triosephosphate isomerase (TPI) (25 kDa), carbonic anhydrase (CA) (25 kDa) and creatinine kinase‐brain (CKB) isoform (45 kDa).Conclusions and Inferences: We identify three antigen targets, TPI, CA, and CKB isoform, which are recognized by sera from patients with achalasia.